We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Clinical Note |

Airway Augmentation and Maintenance Through Laryngeal Chemodenervation in Children With Impaired Vocal Fold Mobility

Marshall E. Smith, MD; Albert H. Park, MD; Harlan R. Muntz, MD; Steven D. Gray, MD
Arch Otolaryngol Head Neck Surg. 2007;133(6):610-612. doi:10.1001/archotol.133.6.610.
Text Size: A A A
Published online


Botulinum toxin has a variety of therapeutic uses. In the larynx, it has mainly been used to treat the voice disorder known as spasmodic dysphonia. It has also been used to treat some patients with laryngeal disorders affecting breathing.13 These patients were generally found to have excessive laryngeal adduction during respiration.

Children frequently develop airway problems due to impaired vocal fold mobility. They are usually labeled as having bilateral vocal fold paresis or paralysis. It is difficult to document the cause of these disorders with laryngeal electromyography.4 We hypothesized that some of these children may have inappropriate synchrony of abductor and adductor laryngeal motor control due to either central dysfunction or peripheral nerve injury. This has also been termed laryngeal synkinesis.5 We tested this hypothesis by selectively injecting the thyroarytenoid muscles to weaken laryngeal adduction in an attempt to augment airway dimensions.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

4 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles